Co-occurring alteration of NOTCH and DDR pathways serve as novel predictor to efficacious immunotherapy in NSCLC.
Zhimin Zhang(Guangzhou University of Chinese Medicine), Chuan Chen(Sun Yat-sen University), Bicheng Zhang(University of Electronic Science and Technology of China), Jia Luo(Dana-Farber Cancer Institute), Jing Bai(Singapore-MIT Alliance for Research and Technology), Jungang Ma(Army Medical University), Xiaona Su(Army Medical University), Wei Guan(Tongji Hospital), Xuefeng Xia(Xi'an High Tech University), Juan He(First Affiliated Hospital of Xi'an Jiaotong University), Yanfang Guan(Xi'an Jiaotong University), Mingying Geng(Army Medical University), Yanyan Gu(Second Military Medical University), Cheng Shen(Army Medical University)
Cited by 0
Related Papers
Clinical characteristics of 82 cases of death from COVID-19
|PLoS ONE|2020|594
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
|Frontiers in Molecular Biosciences|2020|497
Prognostic Value of C-Reactive Protein in Patients With Coronavirus 2019
|Clinical Infectious Diseases|2020|458
Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
|Frontiers in Immunology|2020|256
Clinical characteristics of 82 death cases with COVID-19
|medRxiv|2020|249